⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)

Official Title: A Phase 3 Randomized, Open-label Clinical Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Versus Intravenous Pembrolizumab, Administered With Chemotherapy, in the First-line Treatment of Participants With Metastatic Non-small Cell Lung Cancer

Study ID: NCT05722015

Study Description

Brief Summary: This study is to assess the pharmacokinetics (PK) and safety of SC MK-3475A vs intravenous (IV) pembrolizumab, administered with chemotherapy in first line treatment of adult participants with metastatic non-small cell lung cancer. The primary hypotheses of this study are MK-3475A subcutaneous (SC) is noninferior to pembrolizumab IV with respect to PK parameters.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

St. Joseph's Hospital and Medical Center-Dignity Health Cancer Institute ( Site 0023), Phoenix, Arizona, United States

Clermont Oncology Center ( Site 0018), Clermont, Florida, United States

Mid Florida Hematology and Oncology Center ( Site 0010), Orange City, Florida, United States

University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0022), Chicago, Illinois, United States

Orchard Healthcare Research Inc. ( Site 0011), Skokie, Illinois, United States

Franciscan Health Lafayette East ( Site 0020), Lafayette, Indiana, United States

Mercy Health-Paducah Medical Oncology and Hematology ( Site 0006), Paducah, Kentucky, United States

Hattiesburg Clinic Hematology/Oncology ( Site 0008), Hattiesburg, Mississippi, United States

Central Care Cancer Center - Bolivar ( Site 0017), Bolivar, Missouri, United States

Instituto Alexander Fleming ( Site 1008), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

Instituto de Investigaciones Clínicas Mar del Plata ( Site 1001), Mar del Plata, Buenos Aires, Argentina

Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 1005), ABB, Caba, Argentina

Sanatorio Parque ( Site 1003), Rosario, Santa Fe, Argentina

Instituto Argentino de Diagnóstico y Tratamiento (IADT) ( Site 1002), Buenos Aires, , Argentina

Clinica Adventista Belgrano-Oncology ( Site 1004), Caba, , Argentina

Hospital Italiano de Córdoba ( Site 1000), Cordoba, , Argentina

CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA-Pesquisa Clínica ( Site 1102), Fortaleza, Ceara, Brazil

Hospital de Câncer de Recife ( Site 1107), Recife, Pernambuco, Brazil

Hospital Nossa Senhora da Conceição-Centro Integrado de Pesquisa em Oncologia ( Site 1100), Porto Alegre, Rio Grande Do Sul, Brazil

Instituto Joinvilense de Hematologia e Oncologia ( Site 1101), Joinville, Santa Catarina, Brazil

A. C. Camargo Cancer Center ( Site 1106), Sao Paulo, , Brazil

IC La Serena Research ( Site 1207), La Serena, Coquimbo, Chile

Oncocentro Valdivia ( Site 1201), Valdivia, Los Rios, Chile

FALP-UIDO ( Site 1203), Santiago, Region M. De Santiago, Chile

Oncovida ( Site 1209), Santiago, Region M. De Santiago, Chile

Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 1210), Santiago, Region M. De Santiago, Chile

Instituto Nacional del Cancer-CR Investigación ( Site 1211), Santiago, Region M. De Santiago, Chile

Bradfordhill-Clinical Area ( Site 1202), Santiago, Region M. De Santiago, Chile

Anhui Provincial Hospital-Cancer Chemotherapy Department ( Site 4503), Hefei, Anhui, China

Beijing Cancer hospital-intrathoratic deparmtment II ( Site 4510), Beijing, Beijing, China

Beijing Peking Union Medical College Hospital-pneumology department ( Site 4501), Beijing, Beijing, China

Beijing Chest Hospital,Capital Medical University ( Site 4511), Beijing, Beijing, China

Chongqing Three Gorges Central Hospital ( Site 4516), Wanzhou, Chongqing, China

Fujian Provincial Cancer Hospital ( Site 4517), Fuzhou, Fujian, China

Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine (, Guangzhou, Guangdong, China

Jiangmen Center Hospital ( Site 4509), Jiangmen, Guangdong, China

ShenZhen People's Hospital ( Site 4504), Shenzhen, Guangdong, China

Wuhan Union Hospital Cancer Center-Cancer center ( Site 4502), Wuhan, Hubei, China

The First Affiliated Hospital of Nanchang University-Respiratory Medicine Department ( Site 4515), Nanchang, Jiangxi, China

The First Affiliated Hospital of Xi'an Jiaotong University ( Site 4520), Xi'an, Shaanxi, China

Fudan University Shanghai Cancer Center-Oncology ( Site 4512), Shanghai, Shanghai, China

Shanxi Cancer Hospital ( Site 4521), Taiyuan, Shanxi, China

Tianjin Chest Hospital ( Site 4518), Tianjin, Tianjin, China

The First Affiliated Hospital, Zhejiang University-Respiratory Department ( Site 4514), Hangzhou, Zhejiang, China

Taizhou Hospital of Zhejiang Province-Respiratory ( Site 4508), Taizhou, Zhejiang, China

Centre Hospitalier de Cornouaille Quimper - Concarneau ( Site 2600), Quimper, Finistere, France

Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau ( Site 2602), Tours, Indre-et-Loire, France

Hopitaux Universitaires Paris Centre-Hopital Cochin ( Site 2603), Paris, , France

Private Practice- Dr. Rixci Augusto Lenin Ramírez ( Site 1404), Ciudad de Guatemala, , Guatemala

MEDI-K CAYALA ( Site 1403), Guatemala, , Guatemala

Centro Regional de Sub Especialidades Médicas SA ( Site 1401), Quetzaltenango, , Guatemala

Centro Medico Integral De Cancerología (CEMIC) ( Site 1400), Quetzaltenango, , Guatemala

Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 2102), Kecskemét, Bacs-Kiskun, Hungary

Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 2103), Szolnok, Jasz-Nagykun-Szolnok, Hungary

Törökbálinti Tüdőgyógyintézet ( Site 2105), Törökbálint, Pest, Hungary

Semmelweis Egyetem-Pulmonológiai Klinika ( Site 2104), Budapest, , Hungary

Országos Korányi Pulmonológiai Intézet-VI. Tüdöbelosztály és Bronchológia ( Site 2100), Budapest, , Hungary

Fujita Health University ( Site 4406), Toyoake, Aichi, Japan

Kurume University Hospital ( Site 4412), Kurume, Fukuoka, Japan

Gunma Prefectural Cancer Center ( Site 4416), Otashi, Gunma, Japan

National Hospital Organization Hokkaido Cancer Center ( Site 4415), Sapporo, Hokkaido, Japan

Kanagawa Cardiovascular and Respiratory Center ( Site 4404), Yokohama, Kanagawa, Japan

Miyagi Cancer Center ( Site 4401), Natori, Miyagi, Japan

Sendai Kousei Hospital ( Site 4400), Sendai, Miyagi, Japan

Kurashiki Central Hospital ( Site 4409), Kurashiki, Okayama, Japan

Kansai Medical University Hospital ( Site 4408), Hirakata, Osaka, Japan

Osaka Medical and Pharmaceutical University Hospital ( Site 4414), Takatsuki, Osaka, Japan

Saitama Prefectural Cancer Center ( Site 4402), Ina-machi, Saitama, Japan

Shizuoka Cancer Center ( Site 4405), Nagaizumi-cho,Sunto-gun, Shizuoka, Japan

Tochigi Cancer Center ( Site 4417), Utsunomiya, Tochigi, Japan

Juntendo University Hospital ( Site 4413), Bunkyo-ku, Tokyo, Japan

National Hospital Organization Kyushu Medical Center ( Site 4411), Fukuoka, , Japan

National Hospital Organization Kyushu Cancer Center ( Site 4410), Fukuoka, , Japan

Osaka International Cancer Institute ( Site 4407), Osaka, , Japan

Nippon Medical School Hospital ( Site 4403), Tokyo, , Japan

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier, Warszawa, Mazowieckie, Poland

Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie-Oddzial Onkologii z Pododdzialem Chemioterapii, Olsztyn, Warminsko-mazurskie, Poland

Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 2801), Koszalin, Zachodniopomorskie, Poland

SC Radiotherapy Center Cluj SRL-Oncologie Medicala ( Site 2303), Florești, Cluj, Romania

Centrul de Oncologie "Sfântul Nectarie"-Medical Oncology ( Site 2301), Craiova, Dolj, Romania

Cabinet Medical Oncomed ( Site 2305), Timișoara, Timis, Romania

Institutul Oncologic-Oncologie Medicala ( Site 2302), Cluj, , Romania

CANCERCARE LANGENHOVEN DRIVE ONCOLOGY CENTRE ( Site 2903), Port Elizabeth, Eastern Cape, South Africa

Medical Oncology Centre of Rosebank ( Site 2907), Johannesburg, Gauteng, South Africa

Steve Biko Academic Hospital-Medical Oncology ( Site 2904), Pretoria, Gauteng, South Africa

Sandton Oncology Medical Group (Pty) Ltd-Research ( Site 2900), Sandton, Gauteng, South Africa

The Oncology Centre ( Site 2901), Durban, Kwazulu-Natal, South Africa

Cape Town Oncology Trials ( Site 2902), Cape Town, Western Cape, South Africa

CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 2404), Santiago de Compostela, La Coruna, Spain

HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-ONCOLOGY ( Site 2401), Madrid, Madrid, Comunidad De, Spain

Hospital Universitari Vall d'Hebron-Oncology ( Site 2400), Barcelona, , Spain

Hospital Universitario Juan Ramon Jimenez-Oncología Medica ( Site 2402), Huelva, , Spain

Changhua Christian Hospital ( Site 4203), Changhua County, Changhua, Taiwan

Chang Gung Memorial Hospital at Kaohsiung ( Site 4200), Kaohsiung Niao Sung Dist, Kaohsiung, Taiwan

National Taiwan University Cancer Center (NTUCC) ( Site 4205), Taipei City, Taipei, Taiwan

Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 4207), Kaohsiung, , Taiwan

E-Da hospital ( Site 4208), Kaohsiung, , Taiwan

National Cheng Kung University Hospital ( Site 4202), Tainan, , Taiwan

National Taiwan University Hospital-Oncology ( Site 4204), Taipei, , Taiwan

Maharaj Nakorn Chiang Mai Hospital ( Site 4300), Muang, Chiang Mai, Thailand

Chulalongkorn University ( Site 4301), Bangkok, Krung Thep Maha Nakhon, Thailand

Division of Medical Oncology, Siriraj H ( Site 4303), Siriraj, Krung Thep Maha Nakhon, Thailand

Songklanagarind hospital ( Site 4302), Hatyai, Songkhla, Thailand

I.E.U. Medical Point Hastanesi-Oncology ( Site 2507), Izmir, Karsiyaka, Izmir, Turkey

Gulhane Egitim Arastirma Hastanesi-Oncology ( Site 2504), Ankara, , Turkey

Hacettepe Universite Hastaneleri-oncology hospital ( Site 2506), Ankara, , Turkey

Ankara City Hospital-Medical Oncology ( Site 2501), Ankara, , Turkey

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2502), Istanbul, , Turkey

Memorial Kayseri Hastanesi ( Site 2500), Kayseri, , Turkey

İnönü Üniversitesi Turgut Özal Tıp Merkezi-medical oncology depertmant ( Site 2503), Malatya, , Turkey

Contact Details

Name: Medical Director

Affiliation: Merck Sharp & Dohme LLC

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: